—
C+
C+ The full Closelook — membership. Open the C+ overview

Bruker Corporation (BRKR) — chart, structure and Closelook read

Home› Indices›
Pick a ticker to load its detail page.

Company snapshot — Bruker Corporation

BRKR in five paragraphs: what it makes and sells, where it sits in the Closelook stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Bruker builds scientific instruments used in research and diagnostics, organised into four segments covering nuclear magnetic resonance and imaging tools, mass spectrometry and molecular diagnostics kits, nanoscale imaging and metrology tools such as atomic force microscopes and X-ray systems, and superconducting wire materials. Its customers span academic labs, biopharma companies, and industrial and clinical testing sites. It is headquartered in Billerica, Massachusetts.
Where it sits in the stack
Bruker carries no seat in our Rubin index and sits instead in our broader Healthcare sleeve, under medical devices and life-science tools; it supplies research and diagnostic instruments rather than components for AI infrastructure.
Who it is priced against
No formal peer group is set for it yet; the market usually compares it with larger life-science instrument makers such as Thermo Fisher Scientific and Agilent Technologies.
Why Closelook tracks it
It holds a seat in the Russell 1000 but carries no Closelook score and has not appeared in the diary's quotes so far.
What the diary watches
Whether demand across its life-science and diagnostics segments holds up as research and biopharma budgets shift.

Bruker Corporation (BRKR) trades on US exchanges.

Written from the company’s public profile and Closelook’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

Signals for this name

Every Closelook reading that exists for BRKR, from the same nightly bakes the boards use. Research diary readings, not advice.

Who it is priced against Medical Devices · United States · 8 names with week and year-to-date

Peer group

Medical Devices · United States

This name carries no Closelook score, so its cohort ranks on trend state — distance to the 50- and 200-day averages — never on a score it does not have.

Compared against BRKR on the nightly bakes; the Peers tab ranks the cohort on the Closelook scores where it exists.

Dividends and capital return trailing yield 0.32%, quarterly · last 0.0506 USD on 2026-06-22

Dividends and capital return

What BRKR pays out and buys back — distributions read from the price series, money terms from the filings.

  • Trailing 12 months 0.20 USD per share · a 0.32% yield on the 2026-09-17 close 4 distributions, paid quarterly 2026-09-17
  • Change on the year +33.7% against the prior twelve months prior twelve months 0.15 USD per share
  • Last distribution 0.0506 USD per share as the price series records it, within days of the ex-date 2026-06-22
  • By calendar year 2023: 0.0500 USD (partial) · 2024: 0.15 USD · 2025: 0.20 USD · 2026: 0.10 USD to date first distribution recorded in the three-year window: 2023-11-30

Per-share amounts are derived from the adjusted price series in the listing currency, so dates sit within days of the ex-date; filing figures come from the fundamentals feed for the last reported fiscal year. An investment diary, not a recommendation.

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 55/100 · S&P 500 fund at 58, above its 50- and 200-day averagesEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-17
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 94th percentile of the window, +2.7% over 20 sessions. Factor regime → 2026-09-17
  • Sovereign pressure Index 0.00 · down 0.41 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-17

FAQ · from the current data · as of 2026-09-18

Quick answers

What is Bruker Corporation (BRKR)?

Bruker Corporation trades as BRKR on the US exchange (United States) in the Closelook research universe, as of the registry build of 2026-09-18.

Is BRKR in a Closelook index?

Not currently — Bruker Corporation is tracked in the Closelook research universe but is not a constituent of a Closelook functional index as of 2026-09-18.

Where does BRKR trade against its moving averages?

Uptrend stack intact: Trades +8.4% vs the 50-day and +30.3% vs the 200-day average, 3.4% below the 52-week high and +110.1% off the 52-week low. Computed from daily closes. As of 2026-09-17 — a technical state from the nightly Closelook bake, not advice. The Technical tab carries the full row.

What does Bruker Corporation do?

Bruker builds scientific instruments used in research and diagnostics, organised into four segments covering nuclear magnetic resonance and imaging tools, mass spectrometry and molecular diagnostics kits, nanoscale imaging and metrology tools such as atomic force microscopes and X-ray systems, and superconducting wire materials. Its customers span academic labs, biopharma companies, and industrial and clinical testing sites. It is headquartered in Billerica, Massachusetts. No formal peer group is set for it yet; the market usually compares it with larger life-science instrument makers such as Thermo Fisher Scientific and Agilent Technologies.

Where does Bruker Corporation sit in the AI build-out?

Bruker carries no seat in our Rubin index and sits instead in our broader Healthcare sleeve, under medical devices and life-science tools; it supplies research and diagnostic instruments rather than components for AI infrastructure. It holds a seat in the Russell 1000 but carries no Closelook score and has not appeared in the diary's quotes so far.

Does Bruker Corporation pay a dividend?

Bruker Corporation has paid 0.20 USD per share over the last twelve months, paid quarterly, a trailing yield of 0.32% on the 2026-09-17 close; the last distribution recorded in the price series was 0.0506 USD on 2026-06-22. The "Dividends and capital return" block on this page carries the lines.

What does this page show?

A live price chart with SMA overlays and drawing tools for BRKR, performance metrics, index-membership context and the Closelook structure read — an investment research diary view, not investment advice.

Related in the Closelook universe

then Medical Devices. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.